C
DAWN

Covestor’s Day One Biopharmaceuticals DAWN Stock Holding History

Covestor’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12
Closed – – 2543
2026
Q1 		$0 Sell
12
-224
-95% -$3.16K ﹤0.01% 2350
2025
Q4 		$2K Buy
236
+181
+329% +$1.51K ﹤0.01% 1903
2025
Q3 		$0 Buy
55
+43
+358% +$296 ﹤0.01% 2360
2025
Q2 		$0 Sell
12
-17
-59% -$117 ﹤0.01% 2299
2025
Q1 		$0 Buy
29
+22
+314% +$237 ﹤0.01% 2311
2024
Q4 		$0 Hold
7
– – ﹤0.01% 2316
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2303
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2317
2024
Q1 		$0 Sell
7
-1
-13% -$15 ﹤0.01% 2317
2023
Q4 		$0 Sell
8
-1
-11% -$12 ﹤0.01% 2230
2023
Q3 		$0 Sell
9
-1
-10% -$13 ﹤0.01% 2207
2023
Q2 		$0 Buy
10
+4
+67% +$52 ﹤0.01% 2218
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2116
2022
Q4 		$0 Hold
6
– – ﹤0.01% 2150
2022
Q3 		$0 Buy
+6
New +$128 ﹤0.01% 2093

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Covestor's DAWN Position: Q2 2026 in Review

Covestor sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 12 shares.

Covestor first reported a position in DAWN in Q3 2022 and held it in 15 quarters. The position peaked at $2K in Q4 2025. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Covestor reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Covestor sold 12 Day One Biopharmaceuticals shares in Q2 2026.
  • Covestor first reported a position in Day One Biopharmaceuticals in Q3 2022 and held it in 15 quarters.
  • Covestor's Day One Biopharmaceuticals position peaked at $2K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.